Latest news
Eli Lilly Announces New Version Of Zepbound With A Month’s Worth Of Doses In KwikPen — How Much Will It Cost? - StocktwitsStocktwits · Sat, 08 Aug 2026 03:23:49 GMTEli Lilly Launches Attacks On Tirzepatide Generics - Law360Law360 · Fri, 07 Aug 2026 20:01:00 GMTThe Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2 - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 07:00:00 GMTModerna launches early trial of Ebola mRNA vaccine - STATSTAT · Wed, 05 Aug 2026 19:34:10 GMTLilly confident in slow and steady Foundayo launch, as ex-US sales shine - BioSpaceBioSpace · Wed, 05 Aug 2026 18:20:42 GMTDow Jones Top Company Headlines at 9 AM ET: CVS Health Launches Eli Lilly GLP-1 Partnership, Lifts Outlook as Profit Increases | Eli ... - MoomooMoomoo · Wed, 05 Aug 2026 14:02:37 GMTEli Lilly opens narrow early-access door to its experimental obesity drug - Benefits and Pensions MonitorBenefits and Pensions Monitor · Wed, 05 Aug 2026 11:46:23 GMTCVS Health Launches Eli Lilly GLP-1 Partnership, Lifts Outlook as Profit Increases - WSJWSJ · Wed, 05 Aug 2026 10:39:00 GMT